학술논문

Dual Chimeric Antigen Receptor T Cells Targeting CD38 and SLAMF7 with Independent Signaling Demonstrate Preclinical Efficacy and Safety in Multiple Myeloma
Document Type
Journal
Source
CANCER IMMUNOLOGY RESEARCH; APR 2 2024, 12 4, p478-p490, 13p.
Subject
Language
English
ISSN
23266074